A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

1.7K views

⸱

DOI:

10.3791/63374

⸱

April 21st, 2022

 ,  , 

In This Article

Summary

The goal of this method paper is to demonstrate a robust and reproducible methodology for the enrichment, generation, and expansion of primary tumor cell lines from surgically resected pleural mesothelioma.

Abstract

Current methodologies for the expansion of primary tumor cell lines from rare tumor types are lacking. This protocol describes methods to expand primary tumor cells from surgically resected, malignant pleural mesothelioma (MPM) by providing a complete overview of the process from digestion to enrichment, expansion, cryopreservation, and phenotypic characterization. In addition, this protocol introduces concepts for tumor generation that may be useful for multiple tumor types such as differential trypsinization and the impact of dissociation methods on the detection of cell surface markers for phenotypic characterization. The major limitation of this study is the selection of tumor cells that will expand in a two-dimensional (2D) culture system. Variations to this protocol, including three-dimensional (3D) culture systems, media supplements, plate coating to improve adhesion, and alternate disaggregation methods, could improve this technique and the overall success rate of establishing a tumor line. Overall, this protocol provides a base method for establishing and characterizing tumor cells from this rare tumor.

Introduction

Malignant pleural mesothelioma (MPM) is a rare tumor highly associated with asbestos exposure. Although immunotherapy-based approaches have shown encouraging results, there is a paucity of treatment options available to patients that develop this disease, and the overall 5-year survival rate is low1,2. Efforts are underway at multiple institutions to better understand this disease and identify novel therapeutic targets that may improve patient outcomes. While there are multiple mesothelioma mouse models, access to primary mesothelioma tumor cells is more limited3. In vitro expa....

Access restricted. Please log in or start a trial to view this content.

Protocol

All methods described here have been approved by the Institution Review Board (IRB) of the University of Texas MD Anderson Cancer Center. This pertains to standard-of-care, surgically resected MPM tumors removed following informed consent.

1. Preparation of tumor digestion media and other associated media

  1. To prepare tumor digestion media, add 5 mL of 100% Pen/Strep (Penicillin/Streptomycin) to 500 mL of sterile Roswell Park Memorial Institute (RPMI) 1640 medium in a laminar flow hood.
    1. Transfer the medium to a 500 mL, 0.22 µm polyethersulfone (PES) sterile filter for vacuum filtration.
      NO....

Access restricted. Please log in or start a trial to view this content.

Results

To determine fibroblast contamination of early-passage cultures, cells are assessed using an inverted phase microscope to identify the frequency of fibroblasts relative to the other adherent cells present. Figure 1 shows examples of increasing fibroblast contamination of 80% (Figure 1A), 50% (Figure 1B), and 30% (Figure 1C), compared to a culture with no fibroblast contamination (Fi.......

Access restricted. Please log in or start a trial to view this content.

Discussion

While this protocol is straightforward, there are a few critical steps that must be closely followed. The early-passage freeze is important to preserve the ability to repeat the tumor-cell enrichment process if initially unsuccessful. The ability to assess fibroblastic contamination by eye to decide the correct splitting and media starvation technique is vital to preventing fibroblast overgrowth in the culture. In addition, the differential trypsinization method requires careful observation of the cells during incubation.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

CH is a member of the SAB for Briacell Therapeutics and the Mesothelioma Applied Research Foundation. All other authors have nothing to disclose.

Acknowledgements

We would like to acknowledge Raquel Laza-Briviesca for her contribution to starting this protocol and Drs. Boris Sepesi, Reza Mehran, and David Rice for collaboration on tissue collections. There is no additional funding associated with this work.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
10 mL serological pipettesBD Falcon357551
15 mL conical tubesBD Falcon352097
2 mL aspirating pipettesBD Falcon357558
5 mL serological pipettesBD Falcon357543
50 mL conical tubesBD Falcon352098
6-well microplates, tissue culture treatedCorning3516
AccutaseInnovative Cell TechnologiesAT104A protease-collagenase mixture considered to be more effective in preserving epitopes for flow cytometry.
anti-CD325 (N-Cadherin) PEInvitrogen12-3259-42
anti-CD90 PE-Cy7BD Biosciences561558
anti-Mesothelin APCMiltenyi130-118-096
Bovine Serum Albumin 30%SigmaA8577-1L
Cell Dissociation buffer, enzyme-freeThermo Fisher Scientific13151014
Cell strainer (70 µm)Greiner Bio-One542-070
Centrifuge with 15 mL and 50 mL adaptors
Collagenase Type 1Sigma-AldrichC-0130Dissolve 1.5 g of Collagenase type I into 100 mL of sterile DMEM and aliquot in 5 mL volumes. Label well and store at -20 °C.
Controlled-rate freezing chamberThermo Fisher Scientific15-350-50
CryovialsThermo Fisher Scientific5000-0020
CulturPlate-96Packard Instrument Company6005680White, opaque 96-well microplate.
Dimethyl sulfoxideThermo Fisher ScientificBP231-100
DNAse I (from bovine pancreas)Sigma-AldrichD4527Aliquot at 50 μL, label well and store at -20 °C. After thawing, keep at 4 °C for up to 1 month.
Dulbecco's Phosphate buffered saline solution 1xCorning21-031-CV
Ethanol 200 proofThermo Fisher ScientificA4094
FACS tubes-filter topBD Falcon352235
Fetal bovine serumGemini-Bio100-106
GentleMACS C-tubesMiltenyi130-093-237
GentleMACS Octo-dissociator with heater apparatusMiltenyi130-096-427Includes specialized heater apparatus sleeves used to apply heat to the C-tubes during dissocation.
Goat serumSigma-AldrichG9023Aliquot and store at -20 °C.
Hank's Balanced Salt solution, 500 mLCorningMT21022CV
HyaluronidaseSigma-AldrichH3506Dissolve 0.15 g of Hyaluronidase into 100 mlLof sterile DMEM and distribute into 1.0 mL aliquots. Label well and store at -20 °C.
Inverted-phase microscope
Laminar flow hood
Live/dead yellow dyeLife TechnologiesL-34968
Micropipettor tips, 20 µLART2149P
Micropipettor, 0.5-20 µL
Mycoalert assay control setLonzaLT07-518Aliquot positive controls and store at -20 °C.
Mycoalert Plus mycoplasma detection kitLonzaLT07-710Aliquot reagent and substrate and store at -20 °C. Save remaining buffer and aliquot for negative control and store at -20°C.
Paraformaldehyde 16%Electron Microscopy Sciences15710Prepare stock by filtering through a PVDF syringe filter (Millex cat. no. SLVV033RS) and aliquot under a fume hood. Store at -20 °C.
Penicillin-streptomycin 10,000 U/mLGibco15140-122
Pipet aid
Plate reader with luminescent capabilitiesBioTekSynergy HTany plate reader with these specifications can be used
RPMI 1640 mediaCorning10-040-CV
ScalpelAndwin2975#21
Stericup Quick Release-GP sterile vacuum filtration system, 0.22 µm PES Express PLUS, 500 mLEMD MilliporeS2GPU05RE
Steriflip-GP filter, 0.22 µm PES Express PLUS, 50 mLEMD MilliporeSCGP00525
Sterile forcepsThermo Fisher Scientific12-000-157
T25 flasks, tissue culture treatedCorning430639
T75 flasks, tissue culture treatedCorning430641U
Trypan blue solution 0.4%Gibco15250-061
Trypsin EDTA 0.05%Corning25-052-CI
ViaStain acridine orange/propidium iodide (AO/PI) solutionNexcelomCS2-0106-5ML

References

  1. Guzman-Casta, J., et al. Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma. Thoracic Cancer. 12 (7), 1014-1022 (2021).
  2. Baas, P., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Tumor Cell ExpansionPrimary Tumor LinesTumor DissociationDifferential TrypsinizationFibroblast ContaminationPhenotypic CharacterizationFlow CytometryCryopreservationSurface Marker Expression